AG0039AL

726169-73-9 | N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide

AG0039AL

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

• mg
• g
• kg
• ml
• L

No data

• mg
• g
• kg
• ml
• L

No data

No data

Inquire

CAS Number	726169-73-9
Catalog Number	AG0039AL(AGN-PC-0MUSW4)
Chemical Name	N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
EC Number	232-668-6
IUPAC Name	N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
InChI	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
InChI Key	HRNLUBSXIHFDHP-UHFFFAOYSA-N
MDL Number	MFCD10565970
Molecular Formula	C23H20N6O
Molecular Weight	396.4445
SMILES	NC1=C(C=CC=C1)NC(C1=CC=C(C=C1)CNC1=NC=CC(=N1)C=1C=NC=CC1)=O
UNII	A6GWB8T96J
Synonyms	MG 0103, MG 4230, MG 4915, MG 5026, MG-0103, MG-4230, MG-4915, MG-5026, MG0103, MG4230, MG4915, MG5206, MGCD 0103, MGCD-0103, MGCD0103, mocetinostat, N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide, Mocetinostat, 726169-73-9, MGCD0103, MGCD-0103, N-(2-AMINOPHENYL)-4-([[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO]METHYL)BENZAMIDE, MGCD 0103, Mocetinostat (MGCD0103), UNII-A6GWB8T96J, MGCD0103 (Mocetinostat), MGCD0103(Mocetinostat), Mocetinostat (MGCD0103, MG0103), A6GWB8T96J, CHEMBL272980, N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide, Mocetinostat (USAN/INN), N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide, MG0103, Mocetinostat [USAN:INN], MG 0103, N-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide, N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide, Myeloperoxidase (USAN), MGCD010,3Mocetinostat, MGCD0103/Mocetinostat, MGCD0103, Mocetinostat, MGCD0103 - Mocetinostat, MLS006010181, SCHEMBL157027, GTPL7008, BDBM24624, CHEBI:94525, DTXSID80222945, EX-A049, QCR-116, HRNLUBSXIHFDHP-UHFFFAOYSA-N, BCPP000163, HMS3654K06, AOB87751, BCP01814, ABP000144, AN-405, BBL102287, MFCD10565970, s1122, STL556086, ZINC13986811, AKOS016340325, N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide, BCP9000925, BD-0114, CCG-208763, CS-0502, DB11830, RL04767, SB16666, KS-00000T71, NCGC00263182-01, NCGC00263182-02, NCGC00263182-11, AC-30281, AK175950, BC219534, HY-12164, SC-85911, SMR004701289, AB0008035, FT-0741876, SW218130-2, X7532, EC-000.2284, D09641, D09643, W-5447, 169M739, J-522866, BRD-K16485616-001-01-4, BRD-K16485616-001-04-8, MGCD-0103, 726169-73-9, N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2, Benzamide, N-(2-aminophenyl)-4-(((4-(3-pyridinyl)-2-pyrimidinyl)amino)methyl)-, 9003-99-0, N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide;MGCD0103;Mocetinostat;MGCD0103(Mocetinostat), Mocetinostat [USAN], D00FHR, Mocetinostat, MGCD0103, cc-119, C23H20N6O, MG4230, MG4915, MG5206, MG 4230, MG 4915, MG 5026, MG-0103, MG-4230, MG-4915, MG-5026, RW4115, CID9865515, A4089, A10586, C523184, N-(2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] Benzamide,

Complexity	538
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	396.17g/mol
Formal Charge	0
Heavy Atom Count	30
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	396.454g/mol
Monoisotopic Mass	396.17g/mol
Rotatable Bond Count	6
Topological Polar Surface Area	106A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number